Table of Content


1 Industry Outlook
1.1 Medical Devices Industry
1.1.1 Overview
1.1.2 Facial Aesthetics
1.1.2.1 Facial Aesthetics
1.1.2.2 Botox
1.1.2.3 Dermal Fillers
1.1.2.4 Chemical Peel
1.1.2.5 Microdermabrasion
1.1.3 Materials Used in Soft Tissue Fillers
1.1.3.1 Absorbable Materials
1.1.3.2 Non-absorbable Materials
1.1.4 Industry Trends
1.2 Healthcare Spending
1.2.1 US
1.2.2 Europe
1.3 Regulatory Bodies & Standards
1.4 Emerging Global Markets
1.5 Patient Demographics
1.6 PESTLE Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Opportunity Analysis
3.4 Strategic Initiatives
3.5 Related Markets
3.5.1 Facial Aesthetics Market
3.5.2 Dental Implants Market
3.5.3 Breast Implant Market
3.5.4 Energy-based Aesthetic Devices Market
3.6 Porter 5 (Five) Forces
4 Market Characteristics
4.1 Evolution
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rise in focus on physical appearance to reverse the sign of aging
4.2.1.2 Rising geriatric population
4.2.1.3 Increased preference for minimally invasive cosmetic surgeries
4.2.1.4 Increasing awareness about anti-aging skincare measures
4.2.1.5 Increase in disposable income
4.2.2 Restraints
4.2.2.1 Complications and risks associated with facial injectables
4.2.2.2 High cost of facial injectables
4.2.2.3 Threat of counterfeit products in the market
4.2.2.4 Paucity of skilled professionals
4.2.2.1 Intense competition among vendors
4.2.3 Opportunities
4.2.3.1 Technological advancements
4.2.3.2 Upsurge in medical tourism
4.2.3.3 Increase in the demand for combination treatments
4.2.3.4 Increase in healthcare spending
4.2.4 DRO – Impact Analysis
4.3 Product Type Segmentation – Market Size and Forecast
4.3.1 Dermal Fillers
4.3.1.1 Overview
4.3.2 Featured Products
4.3.3 Botox
4.3.3.1 Overview
4.3.4 Featured Products
4.4 Key Stakeholders
5 End-users
5.1 Overview
5.2 Hospitals
5.3 Dermatology Centers
5.4 Physician’s Office
6 Regions
6.1 Overview
6.2 North America
6.2.1 Overview
6.2.2 Market Developments
6.3 Europe
6.3.1 Overview
6.3.2 Market Developments
6.4 APAC
6.4.1 Overview
6.4.2 Market Developments
6.5 Rest of the World
6.5.1 Overview
6.5.2 Market Developments
7 Competitive Landscape
7.1 Competitor Comparison Analysis
7.1.1 Competitiveness
7.1.2 Key Competitive Facts
8 Vendors Profile
8.1 Allergan plc
8.1.1 Overview
8.1.2 Business Units
8.1.3 Business Focus
8.1.4 SWOT Analysis
8.1.5 Business Strategies
8.2 Galderma
8.2.1 Overview
8.2.2 Business Focus
8.2.3 SWOT Analysis
8.2.4 Business Strategies
8.3 Merz Pharma Gmbh & Co. KGaA
8.3.1 Overview
8.3.2 Geographic Presence
8.3.3 Business Focus
8.3.4 SWOT Analysis
8.3.5 Business Strategies
8.4 Ipsen S.A.
8.4.1 Overview
8.4.2 Business Units
8.4.3 Geographic Presence
8.4.4 Business Focus
8.4.5 SWOT Analysis
8.4.6 Business Strategies
9 Companies to Watch For
9.1 Sinclair Pharma Plc
9.1.1 Overview
9.1.2 Business Strategies
9.2 Bloomage BioTechology Corp. Ltd.
9.2.1 Overview
9.2.2 Key Highlights
9.2.3 Business Strategies
9.3 Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International Inc)
9.3.1 Overview
9.3.2 Key Highlights
9.3.3 Business Strategies
10 Other Prominent Vendors
11 Annexure



List of Figures


Charts

CHART 1 GLOBAL MEDICAL DEVICE MARKET BY GEOGRAPHY (2018) 9
CHART 2 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 10
CHART 3 FACIAL INJECTABLES SEGMENTATION BY AESTHETICS TYPES 13
CHART 4 MATERIALS USED IN SOFT TISSUE FILLERS 14
CHART 5 GLOBAL AESTHETIC SURGICAL AND NON-SURGICAL PROCEDURES, 2017 16
CHART 6 NUMBER OF AESTHETIC PROCEDURES PERFORMED IN THE US IN 2018 (MILLION) 17
CHART 7 PERCENTAGE OF AESTHETIC PROCEDURES PERFORMED IN THE US IN 2017 (%) 17
CHART 8 TOP FIVE NON-SURGICAL PROCEDURES IN 2018 (WORLDWIDE) 18
CHART 9 IMPERATIVES OF EMERGING MARKETS 21
CHART 10 WORLD POPULATION AGED 65 YEARS AND ABOVE, 1960–2060 (%) 22
CHART 11 PESTLE ANALYSIS OF FACIAL INJECTABLES MARKET 23
CHART 12 RESEARCH METHODOLOGY OF GLOBAL FACIAL INJECTABLES MARKET 26
CHART 13 GLOBAL MEDICAL AESTEHTIC MARKET OVERVIEW 29
CHART 14 GLOBAL FACIAL INJECTABLES MARKET REVENUE, 2018–2025 ($MILLION) 31
CHART 15 OPPORTUNITY ANALYSIS 33
CHART 16 PORTERS 5 FORCES ON GLOBAL FACIAL INJUECTABLES MARKET 35
CHART 17 FILLER MARKET EVOLUTION IN THE US 36
CHART 18 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 38
CHART 19 DRO - IMPACT ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET 44
CHART 20 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION 45
CHART 21 GLOBAL FACIAL INJECTABLES MARKET 2018 46
CHART 22 GLOBAL FACIAL INJECTABLES MARKET OVERVIEW BY PRODUCTS 2018 ($MILLION) 46
CHART 23 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY PRODUCT, 2018–2025 ($MILLION) 47
CHART 24 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY PRODUCT, 2018–2025 (%) 47
CHART 25 GLOBAL DERMAL FILLERS MARKET BY REVENUE, 2018–2025 ($MILLION) 50
CHART 26 GLOBAL BOTOX MARKET REVENUE, 2018–2025 ($MILLION) 52
CHART 27 KEY STAKEHOLDERS OF GLOBAL FACIAL INJECTABLES MARKET 54
CHART 28 GLOBAL FACIAL INJECTABLES MARKET BY END-USER SEGMENTATION, 2018 (%) 55
CHART 29 BUYING CRITERIA 57
CHART 30 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 AND 2025 (%) 60
CHART 31 GLOBAL FACIAL INJECTABLES MARKET BY REGIONS 2018 ($MILLION) 60
CHART 32 FACIAL INJECTABLES MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION) 61
CHART 33 FACIAL INJECTABLES MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION) 63
CHART 34 FACIAL INJECTABLES MARKET REVENUE IN APAC, 2018–2025 ($MILLION) 65
CHART 35 FACIAL INJECTABLES MARKET REVENUE FORECAST IN REST OF THE WORLD, 2018–2025 ($MILLION) 66
CHART 36 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY GEOGRAPHY, 2018–2025 ($MILLION) 67
CHART 37 GLOBAL FACIAL INJETCABLES MARKET SEGMENTATION BY GEOGRAPHY, 2018–2025 (%) 68
CHART 38 ALLERGAN PLC: OVERVIEW SNAPSHOT 76
CHART 39 ALLERGAN PLC: BUSINESS UNITS 77
CHART 40 ALLERGAN PLC: SWOT ANALYSIS 78
CHART 41 GALDERMA : SWOT ANALYSIS 81
CHART 42 MERZ PHARMA GMBH & CO. KGAA: OVERVIEW SNAPSHOT 85
CHART 43 MERZ PHARMA GMBH & CO. KGAA: GEOGRAPHIC PRESENCE 86
CHART 44 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS 88
CHART 45 IPSEN S.A.: OVERVIEW SNAPSHOT 91
CHART 46 IPSEN S.A.: BUSINESS UNITS 92
CHART 47 IPSEN S.A.: GEOGRAPHIC PRESENCE 92
CHART 48 IPSEN S.A.: SWOT ANALYSIS 93

?

 

List of Tables


Tables

TABLE 1 MEDICAL DEVICES BY CATEGORY 11
TABLE 2 TOP LISTED MEDICAL DEVICES COMPANY IN 2018 12
TABLE 3 FACIAL INJECTABLES MARKET OUTLOOK 31
TABLE 4 AVERAGE COST OF DERMAL FACIAL FILLERS 42
TABLE 5 DRO OF DERMAL FILLERS MARKET 51
TABLE 6 DRO OF BOTOX MARKET 53
TABLE 7 GLOBAL FACIAL INJECTABLES MARKET BY END-USERS 57
TABLE 8 GLOBAL FACIAL INJECTABLES REVENUE BY REGIONS, 2019–2025 ($MILLION) 61
TABLE 9 DRO (NORTH AMERICA) 62
TABLE 10 DRO (EUROPE) 64
TABLE 11 DRO (APAC) 65
TABLE 12 DRO (REST OF THE WORLD) 67
TABLE 13 COMPETITIVE STRUCTURE ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET (2018) 71
TABLE 14 ALLERGAN PLC: PRODUCT OFFERINGS 72
TABLE 15 ALLERGAN PLC: RECENT DEVELOPMENTS 73
TABLE 16 GALDERMA: PRODUCT OFFERINGS 79
TABLE 17 GALDERMA: RECENT DEVELOPMENTS 80
TABLE 18 MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS 84
TABLE 19 MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS 85
TABLE 20 IPSEN S.A.: PRODUCT OFFERINGS 89
TABLE 21 IPSEN S.A.: RECENT DEVELOPMENTS 89
TABLE 22 SINCLAIR PHARMA PLC: SNAPSHOT 95
TABLE 23 SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS 96
TABLE 24 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT 98
TABLE 25 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS 98
TABLE 26 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT 100
TABLE 27 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS 100
TABLE 28 OTHER PROMINENT VENDORS IN THE GLOBAL FACIAL INJECTABLES MARKET 104

?